SCHEMBL15870567

SCHEMBL15870567

N#Cc1ccc(-c2cncc(N[C@@H](CO)c3ccccc3)c2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CCNC P24863 2/20 0.60
▸ CDK8 P49336 2/20 0.60
▸ FDPS P14324 1/20 0.47
▸ CDK2 P24941 3/20 0.44
▸ CDK7 P50613 1/20 0.44
▸ ROCK2 O75116 3/20 0.43
▸ ROCK1 Q13464 3/20 0.43
▸ XDH P47989 1/20 0.43
▸ CYP11B2 P19099 1/20 0.43
▸ MAPK1 P28482 2/20 0.42
▸ MAPK13 O15264 1/20 0.42
▸ RPS6KA5 O75582 1/20 0.42
▸ MAP4K4 O95819 1/20 0.42
▸ PAK4 O96013 1/20 0.42
▸ PRKCG P05129 1/20 0.42
▸ CDK1 P06493 1/20 0.42
▸ PRKACA P17612 1/20 0.42
▸ RPS6KB1 P23443 1/20 0.42
▸ AKT1 P31749 1/20 0.42
▸ AKT2 P31751 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15870515 0.84 CCNC (0.64) CCNCCDK8FDPSCDK2CDK7
SCHEMBL15870508 0.84 CCNC (0.64) CCNCCDK8FDPSCDK2CDK7
SCHEMBL15870552 0.84 CCNC (0.64) CCNCCDK8FDPSCDK2CDK7
SCHEMBL15870506 0.84 CCNC (0.64) CCNCCDK8FDPSCDK2CDK7
SCHEMBL15870566 0.82 CDK8 (0.61) CCNCCDK8FDPSCDK2CDK7
SCHEMBL15870532 0.81 CCNC (0.63) CCNCCDK8FDPSCDK2CDK7
SCHEMBL15870509 0.81 CCNC (0.60) CCNCCDK8FDPSCDK2CDK7
SCHEMBL15870557 0.80 CDK8 (0.59) CCNCCDK8FDPSCDK2CDK7
SCHEMBL15870581 0.78 CDK8 (0.57) CCNCCDK8FDPSCDK2CDK7
SCHEMBL15870558 0.78 CCNC (0.62) CCNCCDK8FDPSCDK2CDK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2014106606-A1 NOVE PHENYL/PYRIDINE SERIES SUBSTITUED BY HYDROXYETHYLAMINO FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2014-07-10 — — WO disclosed
Send feedback